When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
MBRX - Dosing underway in study of Moleculin Bio's WP1066 in pediatric brain tumor
Moleculin Biotech Inc.
Moleculin Biotech (NASDAQ:MBRX) begins patient enrollment in the Emory University Phase 1 clinical trial of WP1066 for the treatment of brain tumors in children.
More news on: Moleculin Biotech, Inc., Healthcare stocks news,